Literature DB >> 24782023

Ovarian tissue cryopreservation and transplantation: a realistic, effective technology for fertility preservation.

Dror Meirow1, Hila Ra'anani, Hannah Biderman.   

Abstract

It is clear that ovarian tissue cryopreservation can serve a very important role in providing fertility preservation. To date, more than 30 live human births have resulted from the transplantation of cryopreserved ovarian tissue, proving the successful implementation of this technique. The ideal conditions for ovarian tissue cryopreservation have yet to be determined, indicating the crucial need for more research in this field. Nonetheless, it is recommended that ovarian tissue cryopreservation be offered as an option to women before undergoing chemotherapy treatment in instances where there is no time to delay for hormonal stimulation and oocyte retrieval.

Entities:  

Mesh:

Year:  2014        PMID: 24782023     DOI: 10.1007/978-1-4939-0659-8_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation.

Authors:  Zohar Gavish; Itay Spector; Gil Peer; Stefan Schlatt; Joachim Wistuba; Hadassa Roness; Dror Meirow
Journal:  J Assist Reprod Genet       Date:  2017-11-03       Impact factor: 3.412

2.  Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation.

Authors:  Alon Kedem; Gil M Yerushalmi; Masha Brengauz; Hila Raanani; Raoul Orvieto; Ariel Hourvitz; Dror Meirow
Journal:  J Assist Reprod Genet       Date:  2018-03-24       Impact factor: 3.412

3.  The role of fertility preservation in patients with endometriosis.

Authors:  L Carrillo; D S Seidman; E Cittadini; D Meirow
Journal:  J Assist Reprod Genet       Date:  2016-01-14       Impact factor: 3.412

Review 4.  New advances in ovarian autotransplantation to restore fertility in cancer patients.

Authors:  Mahmoud Salama; Teresa K Woodruff
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

5.  Influence of mouse strain on ovarian tissue recovery after engraftment with angiogenic factor.

Authors:  Maïté Fransolet; Laurie Henry; Soraya Labied; Marie-Caroline Masereel; Silvia Blacher; Agnès Noël; Jean-Michel Foidart; Michelle Nisolle; Carine Munaut
Journal:  J Ovarian Res       Date:  2015-03-27       Impact factor: 4.234

6.  Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival.

Authors:  Laurie Henry; Maïté Fransolet; Soraya Labied; Silvia Blacher; Marie-Caroline Masereel; Jean-Michel Foidart; Agnès Noel; Michelle Nisolle; Carine Munaut
Journal:  J Ovarian Res       Date:  2016-02-12       Impact factor: 4.234

Review 7.  Fertility Risk Assessment and Preservation in Male and Female Prepubertal and Adolescent Cancer Patients.

Authors:  Nikolaos Zavras; Charalampos Siristatidis; Argyris Siatelis; Anna Koumarianou
Journal:  Clin Med Insights Oncol       Date:  2016-06-28

8.  Cancer and fertility preservation: international recommendations from an expert meeting.

Authors:  Matteo Lambertini; Lucia Del Mastro; Maria C Pescio; Claus Y Andersen; Hatem A Azim; Fedro A Peccatori; Mauro Costa; Alberto Revelli; Francesca Salvagno; Alessandra Gennari; Filippo M Ubaldi; Giovanni B La Sala; Cristofaro De Stefano; W Hamish Wallace; Ann H Partridge; Paola Anserini
Journal:  BMC Med       Date:  2016-01-04       Impact factor: 8.775

9.  Optimal FSH usage in revascularization of allotransplanted ovarian tissue in mice.

Authors:  Wen-Zhi Ma; Xiao-Min Zheng; Chang-Chun Hei; Cheng-Jun Zhao; Sha-Sha Xie; Qing Chang; Yu-Fang Cai; Hua Jia; Xiu-Ying Pei; Yan-Rong Wang
Journal:  J Ovarian Res       Date:  2017-01-17       Impact factor: 4.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.